| related words |
| commercializing |
| abbott |
| expend |
| sufficiently |
| discontinue |
| discover |
| licensee |
| developed |
| incorporate |
| advanced |
| viability |
| weaken |
| exploit |
| viable |
| unproven |
| manufactured |
| faster |
| scale |
| focus |
| succeed |
|
| related documents |
| 1123979--2/12/2009--SENOMYX_INC |
| 1123979--2/14/2008--SENOMYX_INC |
| 1180145--3/14/2008--REPLIDYNE_INC |
| 1273013--3/6/2008--PHARMACOPEIA_INC |
| 1145404--3/28/2008--CRITICAL_THERAPEUTICS_INC |
| 1324518--2/28/2007--Williams_Partners_L.P. |
| 1180145--3/27/2007--REPLIDYNE_INC |
| 1273013--3/19/2007--PHARMACOPEIA_DRUG_DISCOVERY_INC |
| 1145404--3/16/2007--CRITICAL_THERAPEUTICS_INC |
| 1324518--3/3/2006--Williams_Partners_L.P. |
| 1095330--2/27/2007--SYMYX_TECHNOLOGIES_INC |
| 1123979--2/23/2007--SENOMYX_INC |
| 1095330--3/6/2006--SYMYX_TECHNOLOGIES_INC |
| 1123979--3/10/2006--SENOMYX_INC |
| 1273013--3/20/2006--PHARMACOPEIA_DRUG_DISCOVERY_INC |
| 926617--3/17/2006--CIPHERGEN_BIOSYSTEMS_INC |
| 1183765--3/8/2010--THRESHOLD_PHARMACEUTICALS_INC |
| 1080014--2/26/2010--THERAVANCE_INC |
| 1157601--3/11/2010--SYNTA_PHARMACEUTICALS_CORP |
| 1011064--2/25/2010--SUNRISE_SENIOR_LIVING_INC |
|
| related topics |
| {product, candidate, development} |
| {property, intellectual, protect} |
| {gas, price, oil} |
| {operation, international, foreign} |
| {financial, litigation, operation} |
| {cost, operation, labor} |
| {personnel, key, retain} |
| {cost, contract, operation} |
| {product, liability, claim} |
| {product, market, service} |
| {capital, credit, financial} |
| {acquisition, growth, future} |
| {system, service, information} |
| {control, financial, internal} |
| {loan, real, estate} |
| {debt, indebtedness, cash} |
| {condition, economic, financial} |
| {competitive, industry, competition} |
| {customer, product, revenue} |
| {regulation, government, change} |
|